nivisnebart

News

GSK's alliance with Alector to develop two drug candidates for dementia has been terminated in the wake of disappointing clinical trial results.

News

Keenova is hoping that its Xiaflex drug can become the first approved therapy for plantar fibromatosis, a debilitating condition affecting the feet.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.